Long-Lasting Effects of a Single Subcutaneous Dose of Ketamine for Treating Melancholic Depression: A Case Report

被引：31

作者：

Galveza, Veronica ^{[1
]}

O'Keefe, Emily ^{[1
]}

Cotiga, Laura ^{[1
]}

Leyden, John ^{[4
]}

Harper, Simon ^{[2
]}

Glue, Paul ^{[6
]}

Mitchell, Philip B. ^{[1
]}

Somogyi, Andrew A. ^{[5
]}

DeLory, Amanda ^{[3
]}

Loo, Colleen K. ^{[1
]}

机构：

[1] Univ New S Wales, Sch Psychiat, Black Dog Inst, Sydney, NSW 2052, Australia

[2] Univ New S Wales, Sch Med, Sydney, NSW 2052, Australia

[3] Wesley Hosp, Kogarah, NSW, Australia

[4] Royal N Shore Hosp, Dept Anaesthesia & Pain Management, St Leonards, NSW 2065, Australia

[5] Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia

[6] Univ Otago, Dunedin, New Zealand

来源：

BIOLOGICAL PSYCHIATRY | 2014年 / 76卷 / 03期

关键词：

INTRAMUSCULAR KETAMINE; ANTIDEPRESSANT; MOOD;

D O I：

10.1016/j.biopsych.2013.12.010

中图分类号：

Q189 [神经科学];

学科分类号：

071006 [神经生物学];

摘要：

引用

页码：E1 / E2

页数：2

共 14 条

[1]

Ketamine for Depression: Where Do We Go from Here? [J].

Aan Het Rot, Marije ;

Zarate, Carlos A., Jr. ;

Charney, Dennis S. ;

Mathew, Sanjay J. .

BIOLOGICAL PSYCHIATRY, 2012, 72 (07) :537-547

[2]

[Anonymous], 2013, BMJ CASE REP

[3]

Antidepressant effects of ketamine in depressed patients [J].

Berman, RM ;

Cappiello, A ;

Anand, A ;

Oren, DA ;

Heninger, GR ;

Charney, DS ;

Krystal, JH .

BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354

[4]

Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression [J].

Cusin, Cristina ;

Hilton, George Q. ;

Nierenberg, Andrew A. ;

Fava, Maurizio .

AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (08) :868-869

[5]

Dose- and Exposure-Response to Ketamine in Depression [J].

Glue, Paul ;

Gulati, Abhishek ;

Le Nedelec, Martin ;

Duffull, Stephen .

BIOLOGICAL PSYCHIATRY, 2011, 70 (04) :E9-E10

[6]

Intramuscular ketamine in acute depression: A report on two cases [J].

Harihar, Chilukuri ;

Dasari, Padmavathy ;

Srinivas, Jakka Sriramulu .

INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (02) :186-188

[7]

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial [J].

Irwin, Scott A. ;

Iglewicz, Alana ;

Nelesen, Richard A. ;

Lo, Jessica Y. ;

Carr, Connie H. ;

Romero, Sheilani D. ;

Lloyd, Linda S. .

JOURNAL OF PALLIATIVE MEDICINE, 2013, 16 (08) :958-965

[8]

DISSOCIATIVE CONSCIOUS SEDATION, AN ALTERNATIVE TO GENERAL ANESTHESIA FOR LAPAROSCOPIC PERITONEAL DIALYSIS CATHETER IMPLANTATION: A RANDOMIZED TRIAL COMPARING INTRAVENOUS AND SUBCUTANEOUS KETAMINE [J].

Javid, Mihan J. ;

Rahimi, Mojgan ;

Keshvari, Amir .

PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (03) :308-314

[9]

Ketamine as a new treatment for depression: A review of its efficacy and adverse effects [J].

Katalinic, Natalie ;

Lai, Rosalyn ;

Somogyi, Andrew ;

Mitchell, Philip B. ;

Glue, Paul ;

Loo, Colleen K. .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (08) :710-727

[10]

Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression [J].

Lara, Diogo R. ;

Bisol, Luisa W. ;

Munari, Luciano R. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (09) :2111-2117

← 1 2 →